DNA damage and polyploidization

Advances in Experimental Medicine and Biology

Volumn 675, Issue , 2010, Pages 57-71

  Chow, Jeremy P H ^b   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; PROTEIN TYROSINE PHOSPHATASE; RAD50 PROTEIN; CYCLIN DEPENDENT KINASE; PROTEIN P21; PROTEIN P53; TP53 PROTEIN, HUMAN;

ANEUPLOIDY; ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL TRANSFORMATION; CHROMOSOMAL INSTABILITY; CYTOKINESIS; DNA DAMAGE; DNA MODIFICATION; DNA REPAIR; DNA REPLICATION; ENDOSPERM; GENE MUTATION; MICROTUBULE; MITOSIS SPINDLE; MOLECULAR DOCKING; NONHUMAN; ONCOGENE; POLYPLOIDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TETRAPLOIDY; BINDING AFFINITY; BINDING SITE; CANCER GROWTH; CANCER STAGING; CANCER THERAPY; CELL FUSION; DNA DAMAGE CHECKPOINT; ENZYME INACTIVATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOME ANALYSIS; M PHASE CELL CYCLE CHECKPOINT; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NEOPLASM; PROTEIN DNA BINDING; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; CELL CYCLE S PHASE; CHROMOSOME SEGREGATION; HUMAN; HUMAN CHROMOSOME; METABOLISM; MITOSIS; REVIEW;

ANIMALS; CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN; DNA DAMAGE; HUMANS; MITOSIS; POLYPLOIDY; S PHASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955916532     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-6199-0_4     Document Type: Article

References (134)

1. Duesberg P, Li R. Multistep carcinogenesis: A chain reaction of aneuploidizations. Cell Cycle 2003; 2(3):202-210.
2. Boveri T. Concerning the Origin of Malignant Tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci 2008; 121(1):S1-S84.
3. Sotillo R, Hernando E, Diaz-Rodriguez E et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 2007; 11(1):9-23. (Pubitemid 46054519)
4. Weaver BA, Silk AD, Montagna C et al. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007; 11(1):25-36. (Pubitemid 46070223)
5. Woo RA, Poon RYC. Gene mutations and aneuploidy: The instability that causes cancer. Cell Cycle 2004; 3(9):1101-1103. (Pubitemid 40268621)
6. Storchova Z, Kuffer C. The consequences of tetraploidy and aneuploidy. J Cell Sci 2008; 121(Pt 23):3859-3866.
7. Barrett MT, Pritchard D, Palanca-Wessels C et al. Molecular phenotype of spontaneously arising 4N (G2-tetraploid) intermediates of neoplastic progression in Barrett's esophagus. Cancer Res 2003; 63(14):4211-4217. (Pubitemid 36917948)
8. Galipeau PC, Cowan DS, Sanchez CA et al. 17p (p53) allelic losses, 4N (G2/tetraploid) populations and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci USA 1996; 93(14):7081-7084. (Pubitemid 26243505)
9. Maley CC. Multistage carcinogenesis in Barrett's esophagus. Cancer Lett 2007; 245(1-2):22-32. (Pubitemid 44959370)
10. Stiff T, O'Driscoll M, Rief N et al. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 2004; 64(7):2390-2396. (Pubitemid 38523891)
11. Olaharski AJ, Sotelo R, Solorza-Luna G et al. Tetraploidy and chromosomal instability are early events during cervical carcinogenesis. Carcinogenesis 2006; 27(2):337-343. (Pubitemid 43167913)
12. Mayer VW, Aguilera A. High levels of chromosome instability in polyploids of Saccharomyces cerevisiae. Mutat Res 1990; 231(2):177-186. (Pubitemid 20252550)
13. Storchova Z, Breneman A, Cande J et al. Genome-wide genetic analysis of polyploidy in yeast. Nature 2006; 443(7111):541-547. (Pubitemid 44527285)
14. Cowell JK. Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. J Natl Cancer Inst 1980; 65(5):955-961. (Pubitemid 11215023)
15. Fujiwara T, Bandi M, Nitta M et al. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 2005; 437(7061):1043-1047. (Pubitemid 41486987)
16. Duelli D, Lazebnik Y. Cell-to-cell fusion as a link between viruses and cancer. Nat Rev Cancer 2007; 7(12):968-976. (Pubitemid 350165858)
17. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194(4260):23-28.
18. Ohno S. Evolution by gene duplication. New York, Springer-Verlag, 1970.
19. Furlong RF, Holland PW. Were vertebrates octoploid? Philos Trans R Soc Lond B Biol Sci 2002; 357(1420):531-544. (Pubitemid 34494815)
20. Senovilla L, Vitale I, Galluzzi L et al. p53 represses the polyploidization of primary mammary epithelial cells by activating apoptosis. Cell Cycle 2009; 8(9):1380-1385.
21. Shi Q, King RW. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 2005; 437(7061):1038-1042. (Pubitemid 41486986)
22. Nigg EA. Centrosome aberrations: Cause or consequence of cancer progression? Nat Rev Cancer 2002; 2(11):815-825. (Pubitemid 37328900)
23. Gergely F, Basto R. Multiple centrosomes: Together they stand, divided they fall. Genes Dev 2008; 22(17):2291-2296.
24. Basto R, Brunk K, Vinadogrova T et al. Centrosome amplification can initiate tumorigenesis in flies. Cell 2008; 133(6):1032-1042. (Pubitemid 351787756)
25. Borel F, Lohez OD, Lacroix FB et al. Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells. Proc Natl Acad Sci USA 2002; 99(15):9819-9824. (Pubitemid 34831131)
26. Kwon M, Godinho SA, Chandhok NS et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008; 22(16):2189-2203.
27. Quintyne NJ, Reing JE, Hoffelder DR et al. Spindle multipolarity is prevented by centrosomal clustering. Science 2005; 307(5706):127-129. (Pubitemid 40093495)
28. Yang Z, Loncarek J, Khodjakov A et al. Extra centrosomes and/or chromosomes prolong mitosis in human cells. Nat Cell Biol 2008; 10(6):748-751. (Pubitemid 351772940)
29. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature 2009; 460(7252):278-282.
30. Barski G, Sorieul S, Cornefert F. [Production of cells of a "hybrid" nature in culturs in vitro of 2 cellular strains in combination.]. C R Hebd Seances Acad Sci 1960; 251:1825-1827.
31. Goldenberg DM, Pavia RA, Tsao MC. In vivo hybridisation of human tumour and normal hamster cells. Nature 1974; 250(5468):649-651.
32. Pawelek JM. Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 2005; 6(12):988-993. (Pubitemid 41685232)
33. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8(5):379-393. (Pubitemid 46643240)
34. Rieder CL, Maiato H. Stuck in division or passing through: What happens when cells cannot satisfy the spindle assembly checkpoint. Dev Cell 2004; 7(5):637-651. (Pubitemid 39462685)
35. Weaver BA, Cleveland DW. Decoding the links between mitosis, cancer and chemotherapy: The mitotic checkpoint, adaptation and cell death. Cancer Cell 2005; 8(1):7-12. (Pubitemid 40991810)
36. Brito DA, Rieder CL. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr Biol 2006; 16(12):1194-1200. (Pubitemid 43867292)
37. Lanni JS, Jacks T. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol Cell Biol 1998; 18(2):1055-1064. (Pubitemid 28063440)
38. Chan YW, On KF, Chan WM et al. The kinetics of p53 activation versus cyclin E accumulation underlies the relationship between the spindle-assembly checkpoint and the postmitotic checkpoint. J Biol Chem 2008; 283(231):15716-15723.
39. Liu Y, Heilman SA, Illanes D et al. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy. Cancer Res 2007; 67(6):2603-2610. (Pubitemid 46548946)
40. Vogel C, Kienitz A, Hofmann I et al. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy. Oncogene 2004; 23(41):6845-6853. (Pubitemid 39279985)
41. Steigemann P, Wurzenberger C, Schmitz MH et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. Cell 2009; 136(3):473-484.
42. Cimini D, Mattiuzzo M, Torosantucci L et al. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. Mol Biol Cell 2003; 14(9):3821-3833. (Pubitemid 37151628)
43. Gisselsson D, Pettersson L, Hoglund M et al. Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci USA 2000; 97(10):5357-5362. (Pubitemid 30313723)
44. Andreassen PR, Lohez OD, Lacroix FB et al. Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1. Mol Biol Cell 2001; 12(5):1315-1328. (Pubitemid 33044413)
45. Uetake Y, Loncarek J, Nordberg JJ et al. Cell cycle progression and de novo centriole assembly after centrosomal removal in untransformed human cells. J Cell Biol 2007; 176(2):173-182. (Pubitemid 46143258)
46. Wong C, Stearns T. Mammalian cells lack checkpoints for tetraploidy, aberrant centrosome number and cytokinesis failure. BMC Cell Biol 2005; 6(1):6.
47. Dalton WB, Nandan MO, Moore RT et al. Human cancer cells commonly acquire DNA damage during mitotic arrest. Cancer Res 2007; 67(24):11487-11492.
48. Quignon F, Rozier L, Lachages AM et al. Sustained mitotic block elicits DNA breaks: One-step alteration of ploidy and chromosome integrity in mammalian cells. Oncogene 2007; 26(2):165-172. (Pubitemid 46095728)
49. Blagosklonny MV. Prolonged mitosis versus tetraploid checkpoint: How p53 measures the duration of mitosis. Cell Cycle 2006; 5(9):971-975.
50. Grafi G, Larkins BA. Endoreduplication in Maize Endosperm: Involvement of M Phase-Promoting Factor Inhibition and Induction of S Phase-Related Kinases. Science 1995; 269(5228):1262-1264.
51. Sigrist SJ, Lehner CF. Drosophila fizzy-related down-regulates mitotic cyclins and is required for cell proliferation arrest and entry into endocycles. Cell 1997; 90(4):671-681. (Pubitemid 27357959)
52. Zhang Y, Wang Z, Liu DX et al. Ubiquitin-dependent degradation of cyclin B is accelerated in polyploid megakaryocytes. J Biol Chem 1998; 273(3):1387-1392. (Pubitemid 28133657)
53. Itzhaki JE, Gilbert CS, Porter AC. Construction by gene targeting in human cells of a "conditional" CDC2 mutant that rereplicates its DNA. Nat Genet 1997; 15(3):258-265. (Pubitemid 27098718)
54. Di Fiore B, Pines J. Emi1 is needed to couple DNA replication with mitosis but does not regulate activation of the mitotic APC/C. J Cell Biol 2007; 177(3):425-437. (Pubitemid 46718272)
55. Machida YJ, Dutta A. The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev 2007; 21(2):184-194. (Pubitemid 46155812)
56. Woo RA, Poon RY. Cyclin-dependent kinases and S phase control in mammalian cells. Cell Cycle 2003; 2(4):316-324.
57. Parrilla-Castellar ER, Arlander SJ, Karnitz L. Dial 9-1-1 for DNA damage: The Rad9-Hus1-Rad1 (9-1-1) clamp complex. DNA Repair (Amst) 2004; 3(8-9):1009-1014. (Pubitemid 38997943)
58. Jhanwar-Uniyal M. BRCA1 in cancer, cell cycle and genomic stability. Front Biosci 2003; 8:s1107-17. (Pubitemid 38925373)
59. Wang Y, Cortez D, Yazdi P et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 2000; 14(8):927-939. (Pubitemid 30253002)
60. Cimprich KA, Cortez D. ATR: An essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008; 9(8):616-627. (Pubitemid 352032926)
61. Petermann E, Caldecott KW. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 2006; 5(19):2203-2209. (Pubitemid 44546554)
62. Freire R, van Vugt MA, Mamely I et al. Claspin: Timing the cell cycle arrest when the genome is damaged. Cell Cycle 2006; 5(24):2831-2834. (Pubitemid 44953930)
63. Bassermann F, Frescas D, Guardavaccaro D et al. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 2008; 134(2):256-267. (Pubitemid 352010329)
64. Boutros R, Dozier C, Ducommun B. The when and wheres of CDC25 phosphatases. Curr Opin Cell Biol 2006; 18(2):185-191. (Pubitemid 43375887)
65. Chen Y, Poon RY. The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability. Front Biosci 2008; 13:5016-5029. (Pubitemid 351599655)
66. Boutros R, Lobjois V, Ducommun B. CDC25 phosphatases in cancer cells: Key players? Good targets? Nat Rev Cancer 2007; 7(7):495-507. (Pubitemid 46985396)
67. Lee J, Kumagai A, Dunphy WG. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 2001; 12(3):551-563. (Pubitemid 33052011)
68. Rothblum-Oviatt CJ, Ryan CE, Piwnica-Worms H. 14-3-3 binding regulates catalytic activity of human Wee1 kinase. Cell Growth Differ 2001; 12(12):581-589. (Pubitemid 34084111)
69. Chan TA, Hermeking H, Lengauer C et al. 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401(6753):616-620.
70. Zdzienicka MZ. Mammalian X ray sensitive mutants: A tool for the elucidation of the cellular response to ionizing radiation. Cancer Surv 1996; 28:281-293. (Pubitemid 27023764)
71. Rhind N, Russell P. Checkpoints: It takes more than time to heal some wounds. Curr Biol 2000; 10(24):R908-11. (Pubitemid 32062650)
72. Falck J, Mailand N, Syljuasen RG et al. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001; 410(6830):842-847. (Pubitemid 32303786)
73. Sorensen CS, Syljuasen RG, Falck J et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003; 3(3):247-258. (Pubitemid 37443880)
74. Falck J, Petrini JH, Williams BR et al. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 2002; 30(3):290-294.
75. Jessberger R, Riwar B, Baechtold H et al. SMC proteins constitute two subunits of the mammalian recombination complex RC-1. EMBO J 1996; 15(15):4061-4068. (Pubitemid 26289815)
76. Michaelis C, Ciosk R, Nasmyth K. Cohesins: Chromosomal proteins that prevent premature separation of sister chromatids. Cell 1997; 91(1):35-45. (Pubitemid 27431311)
77. Kim ST, Xu B, Kastan MB. Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. Genes Dev 2002; 16(5):560-570. (Pubitemid 34212489)
78. Levine AJ, Hu W, Feng Z. The P53 pathway: What questions remain to be explored? Cell Death Differ 2006; 13(6):1027-1036.
79. Chehab NH, Malikzay A, Stavridi ES et al. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96(24):13777-13782.
80. Shieh SY, Ikeda M, Taya Y et al. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91(3):325-334. (Pubitemid 27467963)
81. Chehab NH, Malikzay A, Appel M et al. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. Genes Dev 2000; 14(3):278-288. (Pubitemid 30106483)
82. Hirao A, Kong YY, Matsuoka S et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287(5459):1824-1827.
83. Shieh SY, Ahn J, Tamai K et al. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev 2000; 14(3):289-300. (Pubitemid 30106484)
84. Bunz F, Dutriaux A, Lengauer C et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282(5393):1497-1501. (Pubitemid 28538613)
85. Lee J, Kim JA, Barbier V et al. DNA damage triggers p21WAF1-dependent Emi1 down-regulation that maintains G2 arrest. Mol Biol Cell 2009; 20(7):1891-1902.
86. Andreassen PR, Lacroix FB, Lohez OD et al. Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 2001; 61(20):7660-7668. (Pubitemid 32995063)
87. Chu K, Teele N, Dewey MW et al. Computerized video time lapse study of cell cycle delay and arrest, mitotic catastrophe, apoptosis and clonogenic survival in irradiated 14-3-3sigma and CDKN1A (p21) knockout cell lines. Radiat Res 2004; 162(3):270-286. (Pubitemid 39295428)
88. Ivanov A, Cragg MS, Erenpreisa J et al. Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks. J Cell Sci 2003; 116(Pt 20):4095-4106. (Pubitemid 37337084)
89. Bohm N, Sandritter W. DNA in human tumors: A cytophotometric study. Curr Top Pathol 1975; 60:151-219.
90. Blagosklonny MV. Drug-resistance enables selective killing of resistant leukemia cells: Exploiting of drug resistance instead of reversal. Leukemia 1999; 13(12):2031-2035.
91. Puig PE, Guilly MN, Bouchot A et al. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biol Int 2008; 32(9):1031-1043.
92. Nitta M, Kobayashi O, Honda S et al. Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 2004; 23(39):6548-6558. (Pubitemid 39265518)
93. Decordier I, Kirsch-Volders M. The in vitro micronucleus test: From past to future. Mutat Res 2006; 607(1):2-4.
94. Acilan C, Potter DM, Saunders WS. DNA repair pathways involved in anaphase bridge formation. Genes Chromosomes Cancer 2007; 46(6):522-531. (Pubitemid 46649567)
95. Fingert HJ, Chang JD, Pardee AB. Cytotoxic, cell cycle and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res 1986; 46(5):2463-2467. (Pubitemid 16120714)
96. Chang BD, Broude EV, Fang J et al. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 2000; 19(17):2165-2170. (Pubitemid 30251382)
97. Castedo M, Perfettini JL, Roumier T et al. Cell death by mitotic catastrophe: A molecular definition. Oncogene 2004; 23(16):2825-2837. (Pubitemid 38638845)
98. Vogel C, Hager C, Bastians H. Mechanisms of mitotic cell death induced by chemotherapy-mediated G2 checkpoint abrogation. Cancer Res 2007; 67(1):339-345. (Pubitemid 46142793)
99. Lavin MF, Khanna KK. ATM: The protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int J Radiat Biol 1999; 75(10):1201-1214. (Pubitemid 29500002)
100. Takai H, Naka K, Okada Y et al. Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription. EMBO J 2002; 21(19):5195-5205.
101. Lam MH, Liu Q, Elledge SJ et al. Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 2004; 6(1):45-59. (Pubitemid 38903161)
102. Niida H, Tsuge S, Katsuno Y et al. Depletion of Chk1 leads to premature activation of Cdc2-cyclin B and mitotic catastrophe. J Biol Chem 2005; 280(47):39246-39252. (Pubitemid 41713877)
103. Blasina A, Paegle ES, McGowan CH. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol Biol Cell 1997; 8(6):1013-1023. (Pubitemid 27276322)
104. Chow JPH, Siu WY, Ho HTB et al. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 2003; 278(42):40815-40828. (Pubitemid 37280899)
105. Blasina A, Price BD, Turenne GA et al. Caffeine inhibits the checkpoint kinase ATM. Curr Biol 1999; 9(19):1135-1138. (Pubitemid 29504487)
106. Hall-Jackson CA, Cross DA, Morrice N et al. ATR is a caffeine-sensitive, DNA-activated protein kinase with a substrate specificity distinct from DNA-PK. Oncogene 1999; 18(48):6707-6713.
107. Sarkaria JN, Busby EC, Tibbetts RS et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 1999; 59(17):4375-4382. (Pubitemid 29418757)
108. Wang Q, Fan S, Eastman A et al. UCN-01: A potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J Natl Cancer Inst 1996; 88(14):956-965. (Pubitemid 26239383)
109. Graves PR, Yu L, Schwarz JK et al. The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 2000; 275(8):5600-5605. (Pubitemid 30115197)
110. Tse AN, Schwartz GK. Potentiation of cytotoxicity of topoisomerase i poison by concurrent and sequential treatment with the checkpoint inhibitor UCN-01 involves disparate mechanisms resulting in either p53-independent clonogenic suppression or p53-dependent mitotic catastrophe. Cancer Res 2004; 64(18):6635-6644. (Pubitemid 39297924)
111. Busby EC, Leistritz DF, Abraham RT et al. The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1. Cancer Res 2000; 60(8):2108-2112. (Pubitemid 30225168)
112. Castedo M, Perfettini JL, Roumier T et al. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe. Oncogene 2004; 23(25):4353-4361. (Pubitemid 38850414)
113. Carney JP, Maser RS, Olivares H et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: Linkage of double-strand break repair to the cellular DNA damage response. Cell 1998; 93(3):477-486. (Pubitemid 28232091)
114. Luo G, Yao MS, Bender CF et al. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development and sensitivity to ionizing radiation. Proc Natl Acad Sci USA 1999; 96(13):7376-7381. (Pubitemid 29299669)
115. Xiao Y, Weaver DT. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res 1997; 25(15):2985-2991. (Pubitemid 27331390)
116. Zhu J, Petersen S, Tessarollo L et al. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol 2001; 11(2):105-109. (Pubitemid 32116842)
117. Williams BR, Mirzoeva OK, Morgan WF et al. A murine model of Nijmegen breakage syndrome. Curr Biol 2002; 12(8):648-653. (Pubitemid 34315848)
118. Reina-San-Martin B, Nussenzweig MC, Nussenzweig A et al. Genomic instability, endoreduplication and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci USA 2005; 102(5):1590-1595. (Pubitemid 40209212)
119. Perry MB, Lehman JM. Activities of SV40 T antigen necessary for the induction of tetraploid DNA content in permissive CV-1 cells. Cytometry 1998; 31(4):251-259. (Pubitemid 28162976)
120. Wu X, Avni D, Chiba T et al. SV40 T antigen interacts with Nbs1 to disrupt DNA replication control. Genes Dev 2004; 18(11):1305-1316. (Pubitemid 38720598)
121. Castedo M, Coquelle A, Vivet S et al. Apoptosis regulation in tetraploid cancer cells. EMBO J 2006; 25(11):2584-2595. (Pubitemid 44012240)
122. Hau PM, Siu WY, Wong N et al. Polyploidization increases the sensitivity to DNA-damaging agents in mammalian cells. FEBS Lett 2006; 580(19):4727-4736. (Pubitemid 44189395)
123. Mable BK, Otto SP. Masking and purging mutations following EMS treatment in haploid, diploid and tetraploid yeast (Saccharomyces cerevisiae). Genet Res 2001; 77(1):9-26. (Pubitemid 32220061)
124. Nagy A, Gocza E, Diaz EM et al. Embryonic stem cells alone are able to support fetal development in the mouse. Development 1990; 110(3):815-821.
125. Castedo M, Coquelle A, Vitale I et al. Selective resistance of tetraploid cancer cells against DNA damage-induced apoptosis. Ann N Y Acad Sci 2006; 1090:35-49. (Pubitemid 47092106)
126. Gregory TR. Coincidence, coevolution, or causation? DNA content, cell size and the C-value enigma. Biol Rev Camb Philos Soc 2001; 76(1):65-101. (Pubitemid 32197946)
127. Nurse P. The genetic control of cell volume. In: Cavalier-Smith T, ed. The Evolution of Genome Size. Hoboken:John Wiley and Sons, 1985:185-196.
128. Henery CC, Bard JB, Kaufman MH. Tetraploidy in mice, embryonic cell number and the grain of the developmental map. Dev Biol 1992; 152(2):233-241.
129. Comai L. The advantages and disadvantages of being polyploid. Nat Rev Genet 2005; 6(11):836-846.
130. Hunt T. You never know: Cdk inhibitors as anti-cancer drugs. Cell Cycle 2008; 7(24):3789-3790.
131. Chan YW, Ma HT, Wong W et al. CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle 2008; 7(10):1449-1461. (Pubitemid 351872584)
132. Fischer PM, Gianella-Borradori A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opin Investig Drugs 2005; 14(4):457-477. (Pubitemid 40711855)
133. Therman E, Kuhn EM. Mitotic modifications and aberrations in cancer. Crit Rev Oncog 1989; 1(3):293-305.
134. Erenpreisa J, Cragg MS. Mitotic death: A mechanism of survival? A review. Cancer Cell Int 2001; 1(1):1.